207_Combined course Presentations
ACT II CR at 26 weeks
MMC
CisP
Difference (95% CI) +0.9% (-4.9 to 3.1)
P value
90.5% (391/432)
89.6% (386/431)
p =0.64
Progressive disease
5.1% (22/432)
3.5% (13/431)
Made with FlippingBook
ACT II CR at 26 weeks
MMC
CisP
Difference (95% CI) +0.9% (-4.9 to 3.1)
P value
90.5% (391/432)
89.6% (386/431)
p =0.64
Progressive disease
5.1% (22/432)
3.5% (13/431)
Made with FlippingBook